Lilly To Donate COVID-19 Treatment Baricitinib To India - Quick Facts

Eli Lilly and Co. (LLY) Tuesday announced new initiatives in India in its efforts to help surging COVID-19 patients. The drug major is making an initial donation of 400,000 baricitinib tablets immediately to the Indian government for eligible hospitalized COVID-19 patients in the country.

The company added that it will work urgently to increase the quantity of donated product multifold over the coming weeks.

Lilly said it is offering donations of baricitinib to the Indian government through Direct Relief. The company is also working with local Indian pharmaceutical companies at the same time to execute royalty-free voluntary licensing agreements to accelerate the manufacturing and distribution of the medicine in India during the pandemic.

On Monday, Lilly received emergency use authorization by the Central Drugs Standard Control Organization, a division of Ministry of Health, for its usage in eligible hospitalized COVID-19 patients requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation or ECMO.

Baricitinib is an oral medication currently registered in India for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs.

Baricitinib is authorized for use under an Emergency Use Authorization or EUA in combination with remdesivir, for treatment of suspected or laboratory confirmed coronavirus disease 2019 in hospitalized adults and pediatric patients 2 years of age or older, requiring supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation or ECMO.
Baricitinib has not been approved for the treatment of COVID-19, but has been authorized for emergency use by the FDA.

David A. Ricks, Lilly chairman and CEO, said, "With the COVID-19 crisis devastating India, hospitals are overwhelmed by the number of cases and patients need access to potentially life-saving treatments such as baricitinib. We hope that our donations as well as collaborations with other organizations speed access to baricitinib and provide treatment options for these patients."

Lilly said it continues to evaluate opportunities to provide treatments to COVID-19 patients in countries around the world.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google has revoked its three-year ban on cryptocurrency-related ads on its sites under the search giants' new ad services policy. This action will now allow cryptocurrency exchanges and wallets certified by Google to advertise their products and services on Google's network, beginning August 3, 2021. The UK's competition regulator said Friday that it has secured commitments from Google to address concerns about the tech giant's proposal to remove third-party cookies from Chrome browser. Archer Aviation, a developer of electric vertical take-off and landing or eVTOL aircraft, unveiled its autonomous electric two-seater aircraft, named "Maker", marking a milestone towards its commercial launch. The California-based air mobility company, which has already received orders from United Airlines, will use its inaugural aircraft prototype for testing as it works towards certification.
Follow RTT